Search for:
Search for:
Home
HPS Information
What is HPS?
Characteristics
Lungs
Lung Transplants
Lung Transplant Panel Video
Lung Transplant Considerations
Action Plans
Transplant Team
Preparing for the Evaluation
HPS Transplant Centers
Other Resources
Diagnosing HPS
References
Standard of Care
Media Library
NEWS
NEWSROOM
Media Library
About the Network
Our Mission
Board of Directors
Scientific Advisory Board
Annual Reports
Our Members Photos
OUR MEMBER STORIES
Events
Conferences
MEMBER EVENTS
Virtual Events
Puerto Rico Events
Externally Led PFDD Meeting
ADVOCACY
Legislative Advocacy
Individual Advocacy
Research
Current Research
RESEARCH RESULTS
FLAVIA’S JOURNAL CLUB
Get Involved
Donate
Join the Network
Fundraising
Planned Gift
Contact Us
Store
Home
HPS Information
What is HPS?
Characteristics
Lungs
Lung Transplants
Lung Transplant Panel Video
Lung Transplant Considerations
Action Plans
Transplant Team
Preparing for the Evaluation
HPS Transplant Centers
Other Resources
Diagnosing HPS
References
Standard of Care
Media Library
NEWS
NEWSROOM
Media Library
About the Network
Our Mission
Board of Directors
Scientific Advisory Board
Annual Reports
Our Members Photos
OUR MEMBER STORIES
Events
Conferences
MEMBER EVENTS
Virtual Events
Puerto Rico Events
Externally Led PFDD Meeting
ADVOCACY
Legislative Advocacy
Individual Advocacy
Research
Current Research
RESEARCH RESULTS
FLAVIA’S JOURNAL CLUB
Get Involved
Donate
Join the Network
Fundraising
Planned Gift
Contact Us
Store
CB1R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky–Pudlak syndrome
Aug 28, 2021
View the article at:
https://onlinelibrary.wiley.com/doi/10.1002/ctm2.471
CB1R – and – INOS
(Download this full article in a PDF printable format. 20 pages.)
Click this link or the image below to access the full article.
